Bioharvest Sciences (BHST) EBITDA Margin (2023 - 2026)
Bioharvest Sciences (BHST) posted EBITDA Margin of -22.80% for the quarter ended Jun 30, 2026, down 6.27 percentage points from -16.54% a year earlier and down 6.27 percentage points from the prior quarter.
Bioharvest Sciences (BHST) EBITDA Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Bioharvest Sciences was -13.09%, up 6.20 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -11.45%, up 11.33 percentage points from the prior year.
- In prior years, Bioharvest Sciences' EBITDA Margin was -22.78% in the year ended Dec 31, 2024 (+49.24 pp) and -72.02% in the year ended Dec 31, 2023.
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly EBITDA Margin since the quarter ended Sep 30, 2024.
- On a year-over-year basis, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +38.04 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was the quarter ended Dec 31, 2024, with a gain of 361.31 percentage points; the weakest was the quarter ended Sep 30, 2024, with a drop of 95.44 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -16.53% (quarter ended Mar 31, 2026), -7.59% (quarter ended Dec 31, 2025) and -5.90% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Bioharvest Sciences | 26.70 Mn | -43.69 Mn | 5.08 Mn | -22.80% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.80% |
| Mar 31, 2026 | -16.53% |
| Dec 31, 2025 | -7.59% |
| Sep 30, 2025 | -5.90% |
| Jun 30, 2025 | -16.54% |
| Mar 31, 2025 | -16.79% |
| Dec 31, 2024 | -18.49% |
| Sep 30, 2024 | -26.78% |
| Jun 30, 2024 | -26.81% |
| Mar 31, 2024 | -19.18% |
| Dec 31, 2023 | -379.80% |
| Sep 30, 2023 | 68.66% |
Bioharvest Sciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();